Nasal pharmaceutical formulations and methods of using the same

Details for Australian Patent Application No. 2004229148 (hide)

Owner Mylan Laboratories, Inc.

Inventors Chaudry, Imtiaz

Agent Davies Collison Cave

Pub. Number AU-B-2004229148

PCT Pub. Number WO2004/091575

Priority 10/414,682 16.04.03 US

Filing date 29 March 2004

Wipo publication date 28 October 2004

Acceptance publication date 25 November 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 31/7048 (2006.01)

A61L 2/00 (2006.01) Disinfection or sterilising

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/091575 Priority application(s): WO2004/091575

25 November 2010 Application Accepted

  Published as AU-B-2004229148

2 December 2010 Corrigenda

  Applications Accepted - Name Index Under the name Mylan Laboratories, Inc., Application No. 2004229148, under INID (71) correct the applicant name to Dey Pharma L.P.

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229149-Formulations and methods for treating rhinosinusitis

2004229147-Nasal pharmaceutical formulations and methods of using the same